(Q35826444)

10 August 2017

Performance of the colorectal cancer screening marker Sept9 is influenced by age, diabetes and arthritis: a nested case-control study (English)

1 reference

colorectal cancer screening

10 August 2017

1 reference

1 reference

1 reference

based on heuristic

inferred from title

author

Claus Lindbjerg Andersen

object named as

Claus L Andersen

4

0 references

Hans Jørgen Nielsen

object named as

Hans J Nielsen

2

0 references

author name string

Mai-Britt W Ørntoft

1

1 reference

10 August 2017

Torben F Ørntoft

3

1 reference

10 August 2017

Danish Study Group on Early Detection of Colorectal Cancer

5

1 reference

10 August 2017

language of work or name

English

0 references

publication date

29 October 2015

1 reference

10 August 2017

1 reference

10 August 2017

15

1 reference

10 August 2017

819

1 reference

https://scigraph.springernature.com/pub.10.1186/s12885-015-1832-6

10 August 2017

0 references

cites work

DNA Methylome Signature in Synoviocytes From Patients With Early Rheumatoid Arthritis Compared to Synoviocytes From Patients With Longstanding Rheumatoid Arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4625973

Detection of methylated septin 9 in tissue and plasma of colorectal patients with neoplasia and the relationship to the amount of circulating cell-free DNA.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4625973

Detection of colorectal cancer by DNA methylation biomarker SEPT9: past, present and future

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4625973

Plasma Septin9 versus fecal immunochemical testing for colorectal cancer screening: a prospective multicenter study

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4625973

Detection of circulating tumor DNA in early- and late-stage human malignancies

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4625973

Aberrant septin 9 DNA methylation in colorectal cancer is restricted to a single CpG island.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4625973

Prospective evaluation of methylated SEPT9 in plasma for detection of asymptomatic colorectal cancer

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4625973

The stool DNA test is more accurate than the plasma septin 9 test in detecting colorectal neoplasia

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4625973

SEPT9_i1 and genomic instability: mechanistic insights and relevance to tumorigenesis

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4625973

Circulating methylated SEPT9 DNA in plasma is a biomarker for colorectal cancer

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4625973

Sensitive detection of colorectal cancer in peripheral blood by septin 9 DNA methylation assay

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4625973

DNA methylation biomarkers for blood-based colorectal cancer screening

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4625973

REporting recommendations for tumour MARKer prognostic studies (REMARK)

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4625973

Epigenetic differences arise during the lifetime of monozygotic twins

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4625973

Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4625973

Deoxybonucleic acid (DNA) and antibodies to DNA in the serum of patients with systemic lupus erythematosus

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4625973

Epigenetics and metabolism.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4625973

Validation of a real-time PCR-based qualitative assay for the detection of methylated SEPT9 DNA in human plasma.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4625973

Blood-based testing for colorectal cancer screening

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4625973

Colorectal cancer screening with blood-based biomarkers: cost-effectiveness of methylated septin 9 DNA versus current strategies

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4625973

Survival outcome of patients with screening versus symptomatically detected colorectal cancers.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4625973

Screening for colorectal cancer: possible improvements by risk assessment evaluation?

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4625973

Epigenetic modifications: basic mechanisms and role in cardiovascular disease.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4625973

Diagnostic value of self-reported symptoms in Danish outpatients referred with symptoms consistent with colorectal cancer

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4625973

AGA Future Trends Committee report: Colorectal cancer: a qualitative review of emerging screening and diagnostic technologies

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4625973

Increased levels of circulating DNA in patients with systemic autoimmune diseases: A possible marker of disease activity in Sjögren's syndrome

24 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26514170

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Increased concentrations of antibody-bound circulatory cell-free DNA in rheumatoid arthritis

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26514170

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/S12885-015-1832-6

1 reference

Dimensions Publication ID

10 August 2017

0 references

1 reference

10 August 2017

1 reference